GHK-Cu

Featured

Also known as: Copper Peptide, GHK-Copper

A copper-binding tripeptide with extensive tissue regeneration properties.

Overview

GHK-Cu is a naturally occurring copper complex of the tripeptide Gly-His-Lys. Found in plasma and extracellular matrix, it declines with age and has broad tissue remodeling effects.

Mechanism of Action

Modulates gene expression affecting collagen synthesis, wound healing, immune function, and antioxidant capacity. The copper ion is essential for biological activity. Resets gene expression toward a healthier state.

Pharmacokinetics

Distributed to skin and tissues. Can be applied topically or injected. Copper delivery enhances local enzymatic activity.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Topical

Dose

1-2% cream

Frequency

1-2x daily

Duration

Ongoing

Skincare application

2

Subcutaneous

Dose

1-2 mg

Frequency

Once daily

Duration

4-8 weeks

Systemic anti-aging protocol

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: Tissue repair

Synergy: Deep tissue plus surface healing

Rationale: Anti-aging

Synergy: Cellular and tissue level benefits

Research Areas

Skin AgingWound HealingHair GrowthCOPDTissue Regeneration

Key Research Findings

  • 1Stimulates collagen and glycosaminoglycan synthesis
  • 2Promotes wound healing and tissue remodeling
  • 3Activates stem cells and tissue regeneration
  • 4Gene expression studies show broad anti-aging effects

Side Effects & Contraindications

Reported Side Effects

  • Skin irritation (topical)
  • Generally well-tolerated

Contraindications

  • Wilson's disease
  • Copper sensitivity

Safety Considerations

Well-tolerated. Topical copper peptides widely used in skincare. Systemic dosing less characterized.

Storage Requirements

Store protected from light. Reconstituted at 2-8C.

Scientific References

Quick Reference

Sequence
Gly-His-Lys-Cu
Molecular Weight
403.9 g/mol
Half-Life
Variable by route
Bioavailability
High for topical and SC
Research Stage
clinical phase 2
Administration
Topical, subcutaneous